| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 12/23/2004 | US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof |
| 12/23/2004 | US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 12/23/2004 | US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease |
| 12/23/2004 | US20040259815 Synergistic mixture containing tyrosine kinase inhibitor with carotenoils, flavonoids, apigenin |
| 12/23/2004 | US20040259800 Apoptosis of rectum and prostate cancer |
| 12/23/2004 | US20040259788 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 12/23/2004 | US20040259787 C1q and collectin receptor |
| 12/23/2004 | US20040259110 Gene PRV-1 and its use |
| 12/23/2004 | US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer |
| 12/23/2004 | US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies |
| 12/23/2004 | CA2756058A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 12/23/2004 | CA2528929A1 Cyclic tertiary amine compound |
| 12/23/2004 | CA2528367A1 A1 adenosine receptor antagonists |
| 12/23/2004 | CA2526872A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/22/2004 | EP1489083A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 12/22/2004 | EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
| 12/22/2004 | EP1489071A1 N-substituted, 3,4-dihydro-1H-isoquinoline as potassium channels modulators |
| 12/22/2004 | EP1488808A1 Remedies for glomerular diseases |
| 12/22/2004 | EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders |
| 12/22/2004 | EP1488784A1 Male contraceptive implant |
| 12/22/2004 | EP1487831A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs |
| 12/22/2004 | EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt |
| 12/22/2004 | EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives |
| 12/22/2004 | EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
| 12/22/2004 | EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 12/22/2004 | EP1487807A2 New compounds |
| 12/22/2004 | EP1487806A1 4-anilino quinazoline derivatives as antiproliferative agents |
| 12/22/2004 | EP1487805A1 Pyrimidine derivatives |
| 12/22/2004 | EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 12/22/2004 | EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 12/22/2004 | EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto |
| 12/22/2004 | EP1487458A2 Multi-substitued selective androgen receptor modulators and methods of use thereof |
| 12/22/2004 | EP1487444A1 Use of pyridyl amides as inhibitors of angiogenesis |
| 12/22/2004 | EP1487431A1 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 12/22/2004 | EP1487424A2 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases |
| 12/22/2004 | EP1487272A1 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 12/22/2004 | EP1453949A4 Production of cell suspensions |
| 12/22/2004 | EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 12/22/2004 | EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 12/22/2004 | CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme |
| 12/22/2004 | CN1556709A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 12/22/2004 | CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 12/22/2004 | CN1555869A Preparation technology and use of Chinese herbal medicine phoenix-tail fern |
| 12/22/2004 | CN1555867A Chinese herbal medicinal compositon for treating prostate disease |
| 12/22/2004 | CN1555850A Pure Chinese medicine oral preparation for treating prostate disease and its preparation metod |
| 12/22/2004 | CN1555831A Compound formula preparation eontaining glucocorticoid medicine |
| 12/22/2004 | CN1555822A Prostatitis powder |
| 12/22/2004 | CN1555804A Phenasteroid gel preparation |
| 12/22/2004 | CN1555803A Application of ferulaic acid chuanxiong rhizome qin in preparing medicine |
| 12/22/2004 | CN1555801A Naipaidil slow release preparation |
| 12/22/2004 | CN1555785A Emodin injection preparation and its preparation method |
| 12/22/2004 | CN1181092C Conjugates useful in treatment of prostate cancer |
| 12/22/2004 | CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide |
| 12/22/2004 | CN1180801C Magnetotherapeutic medicinal pad and its preparing process |
| 12/22/2004 | CN1180800C Chinese medicine for curing diseases of kidney and urinary system |
| 12/22/2004 | CN1180784C Application of fur seal oil in preparation of medicine for treating prostatauxe |
| 12/22/2004 | CN1180778C Dibasic acid di (5-androstene-17-one-3 beta-hydroxy) ester used for preparing medicine |
| 12/22/2004 | CN1180777C Medicine for promoting recovery of renal function |
| 12/21/2004 | US6833444 An erythromycin-type antibiotic based on a perhydro-oxazolo(5,4-c)oxacyclotetradecine ring; bactericides; antiprotazoa agents; non-polyene and ansa macrolide antibiotics |
| 12/21/2004 | US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 12/21/2004 | US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders. |
| 12/21/2004 | US6833376 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal |
| 12/21/2004 | US6833372 A hormone inhibitors of gonadotropin releasing hormone, an antigonadotropins, new drug compound contains a furanyl 2-carboxylic acid -(2,4-dimethoxy-pyrimidin-5-yl)-amide groups |
| 12/21/2004 | US6833349 Therapy for skin disorders; psoriasis |
| 12/21/2004 | US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 12/16/2004 | WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF |
| 12/16/2004 | WO2004108674A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these |
| 12/16/2004 | WO2004108645A1 Method for the treatment or prevention of lower urinary tract symptoms |
| 12/16/2004 | WO2004108163A1 Method for preparing powder exhibiting low susceptibility to electrification |
| 12/16/2004 | WO2004108133A2 Modulators of vr1 receptor |
| 12/16/2004 | WO2004108123A1 Preventive and/or remedy for kidney diseases |
| 12/16/2004 | WO2004108119A2 Use of atp or derivatives in medicine |
| 12/16/2004 | WO2004080444B1 Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using cav2.2 subunit calcium channel modulators |
| 12/16/2004 | WO2004064735A3 Treatment of benign prostatic hyperplasia |
| 12/16/2004 | WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency |
| 12/16/2004 | US20040254376 Cyclic amidine derivative |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254249 Nonsteroidal antiinflammatory agents |
| 12/16/2004 | US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 12/16/2004 | US20040254224 Medicaments |
| 12/16/2004 | US20040254223 Process for the preparation of amorphous form of torsemide |
| 12/16/2004 | US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/16/2004 | US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants |
| 12/16/2004 | US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 12/16/2004 | US20040254189 Jnk inhibitors |
| 12/16/2004 | US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects |
| 12/16/2004 | US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 12/16/2004 | US20040254176 Hypotensive agents; cardiovascular disorders; antidiabetic agents; skin disorders;kidney disorders; headaches; vision defects; strokes; synergistic mixture of amlodipine, benazepril and hydrochlorothiazide; oral administering |
| 12/16/2004 | US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 12/16/2004 | US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation |
| 12/16/2004 | US20040253597 Sodium dependent dicarboxylate transport protein for use in identifying modulators for prevention/treatment of hepatic, prostate, splenic, renal diseases, metabolic, circulatory, cancer and aging disorders |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 12/16/2004 | US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | DE102004019765A1 Abgabe von flüssigem transurethralem Prostatabehandlungsmittel Dispensing liquid transurethral prostate treatment agent |
| 12/15/2004 | EP1486497A1 Novel pyridone derivative |
| 12/15/2004 | EP1486494A1 N-substituted benzothiophenesulfonamide derivative |
| 12/15/2004 | EP1486214A1 Botulinum toxins for treating muscle spasm |